1-2 of 2
F. Mark Stewart
Close
Sort by
Journal Articles

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Karamjeet S. Sandhu, Alan Macias, Marissa Del Real, Asuscena L. Beltran, Young Sun Kim, Jianying Zhang, Joycelynne Palmer, Marjorie Robbins, Reyna Loomis, Mojtaba Akhtari, Ahmed Aribi, Shukaib Arslan, Amandeep Salhotra, Matthew Mei, Hoda Pourhassan, Paul B. Koller, Idoroenyi Amanam, Vaibhav Agrawal, Peter T. Curtin, Ricardo Spielberger, Vinod A. Pullarkat, Ibrahim Aldoss, F. Mark Stewart, Eileen P. Smith, Stephen J Forman, Anthony S. Stein, Guido Marcucci, L. Elizabeth Budde
Journal: Blood
Blood (2022) 140 (Supplement 1): 8985–8986.
https://doi.org/10.1182/blood-2022-170279
Published: 2022
Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Adults with Ph-like ALL

Ibrahim Aldoss, Dongyun Yang, Zhaohui Gu, Vanina Tomazian, Sally Mokhtari, Ryan Jackson, Milhan Telatar, Hooi Yew, Monzr M. Al Malki, Amandeep Salhotra, Samer Khaled, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Matthew Mei, Shukaib Arslan, Paul Koller, Andrew S. Artz, Patricia Aoun, Dongqing Gu, David S Snyder, F. Mark Stewart, Peter T. Curtin, Anthony S. Stein, Raju Pillai, Guido Marcucci, Stephen J Forman, Vinod A. Pullarkat, Ryotaro Nakamura, Michelle Afkhami
Journal: Blood
Blood (2021) 138 (Supplement 1): 3955.
https://doi.org/10.1182/blood-2021-153125
Published: 2021